key: cord-0815213-mntjlese authors: Huang, Janice J.; Gaines, Samantha B.; Amezcua, Mateo L.; Lubell, Tamar R.; Dayan, Peter S.; Dale, Marissa; Boneparth, Alexis D.; Hicar, Mark D.; Winchester, Robert; Gorelik, Mark title: Upregulation of Conventional Dendritic Cells type 1 (cDC1) implicates antigen cross presentation in Multisystem Inflammatory Syndrome (MIS-C) date: 2021-10-22 journal: J Allergy Clin Immunol DOI: 10.1016/j.jaci.2021.10.015 sha: 4b07797d9b9326cd3020c884195872a0240b0824 doc_id: 815213 cord_uid: mntjlese Background Multisystem inflammatory syndrome (MIS-C) is an acute, febrile, SARS-CoV-2 associated syndrome, often with cardio-hemodynamic dysfunction. Insight into mechanism of disease is still incomplete. Objective Our objective was to analyze immunologic features of MIS-C patients compared to febrile controls (FC). Methods MIS-C patients were defined by narrow criteria, including having evidence of cardio-hemodynamic involvement and no macrophage activation syndrome (MAS). Samples were collected from eight completely treatment-naive patients with MIS-C (SARS-CoV-2 serology positive), three patients with unclassified “MIS-C-like” disease (serology negative), 14 FC, and 5 MIS-C recovery (RCV). Three healthy controls (HC) were used for normal range comparisons. Using spectral flow cytometry, we assessed 36 parameters in antigen presenting cells (APC) and 29 in T cells. We used biaxial analysis and Uniform Manifold Approximation and Projection (UMAP). Results Significant elevations in cytokines including CXCL9, M-CSF and IL27 were found in MIS-C compared to FC. Classic monocytes and dendritic cell (DC) type 2 were downregulated (decreased CD86, HLA-DR) vs HC, however DC1 (CD11c+CD141+CLEC9A+) were highly activated in MIS-C patients vs FC, expressing higher levels of CD86, CD275, and atypical conventional dendritic cell (cDC) markers such as CD64, CD115, and CX3CR1. CD169 and CD38 were upregulated on multiple monocyte subtypes. CD56dim/CD57-/KLRGhi/CD161+/CD38- NK cells were a unique subset in MIS-C vs FC without MAS. Conclusion Orchestrated by complex cytokine signaling, DC1 activation and NK dysregulation are key features in the pathophysiology of MIS-C. NK cell findings may suggest a relationship with MAS, while DC1 upregulation implies a role for antigen cross presentation upregulation of CD64 on monocytes and neutrophils, upregulation of the interferon-γ axis, 136 and findings suggesting endothelial injury, including notably upregulation of CX3CR1 137 expressing T cells, and HLA Class I associated expansion of T cells. [10] [11] [12] [13] [14] [15] [16] . 138 We sought to comprehensively phenotype cellular markers in the antigen 139 presenting and T cell compartments, with the aim of gaining further insights into 140 mechanisms of disease. While some previous studies have compared patients with MIS-141 C to either patients with acute SARS-CoV-2 infection or HC [7, 8, [11] [12] [13] [14] [15] , Our goal was to 142 identify features that differentiate treatment naïve MIS-C patients from age similar febrile 143 controls (FCs) who were seen in the acute setting during the same time period. We 144 hypothesized that this approach would allow the dissection of features and mechanisms 145 that would prove to be highly specific for MIS-C. Table 1 . 176 MIS-C and FC samples were collected at the time of first presentation and in all 177 cases samples were collected prior to any therapy with corticosteroids or intravenous 178 immunoglobulin. Peripheral blood was collected in EDTA tubes (lavender top) then 179 processed to obtain plasma and cell fractions. Peripheral blood mononuclear cells 180 (PBMCs) were obtained by standard ficoll gradient methods. PBMCs were then 181 cryopreserved in a DMSO/FBS(1:9) mixture, frozen and stored in a liquid nitrogen 182 freezer until samples were run for cytometry. Median time from collection to processing 183 was 7 hours. Plasma was stored at -80 degree centigrade until used for cytokine 184 analysis. 8 MIS-C samples were used for flow cytometry, and 7 for cytokine analysis. One 186 additional MIS-C patient was obtained from a collaborator at University of Buffalo and 187 was analyzed as a separate patient. 5 patients with MIS-C who had been treated 2 188 weeks previously were used as recovery (RCV) samples. (Two of these patients were 189 also part of the 8 patients in the MIS-C set). 14 febrile controls (FC) samples were used 190 for flow cytometry, and 7 for cytokine analysis. FC patients were patients presenting to 191 the emergency department ages 0-21 with long standing (>3 days) fevers, or acute high 192 fever and symptoms concerning for MIS-C and no significant medical co-morbidities. An additional patient was obtained from a collaborator in Buffalo to include as an age-194 similar FC. J o u r n a l P r e -p r o o f 6 3 additional samples were obtained as healthy control (HC) from patients in the 196 emergency room without febrile illnesses (such as minor injuries or headaches). Finally, an additional 3 samples were obtained from patients with a phenotype that 198 appeared similar to either MIS-C or KD, but who were serologically negative for CoV-2 (or who had tested positive several months earlier) or were atypical for KD. For 200 the purposes of this study, we characterized these patents as MIS-C like (MC-like). The patients chosen for cytokine analysis were randomly chosen from all patients 202 and from patients who had more sample volume. Sample volumes of whole blood 203 ranged from 10ml to as little as 1-2ml, and in cases where sample volumes were 204 minimal, only flow cytometry was performed to preserve as many cells as possible. The Table 2 . 213 The study was reviewed and approved by the Institutional Review Board at 214 Columbia University school of medicine (IRB AAAS5915) and the University of Buffalo 215 school of medicine (IRB Study00004340). Cytokine analysis 217 Cytokine assay was performed using a 48-plex cytokine panel (Eve Technologies, 218 Calgary, AB Canada). Samples were sent by dry ice and were validated as being in frozen 219 condition upon arrival. The following cytokines were assayed: sCD40L, EGF, Eotaxin, 220 FGF-2, Flt-3 ligand, Fractalkine, G-CSF, GM-CSF, GROα, IFNα2 , IFNγ, IL-1α, IL-1β, IL-221 1ra, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-15, 222 IL-17A, IL-17E/IL-25, IL-17F, IL-18, IL-22, IL-27, IP-10, (median 74,337 pg/ml vs 378 pg/ml FCs), but for two MIS-C patients they were above the 293 range of detection for the assay, thus data could not be compared for this chemokine. Together, CXCL9 and CXCL10 upregulation suggest a strong interferon-γ signal. Interferon-γ itself also had an upregulated trend (p=0.11). suggests that CD169 responds quickly to treatment, and thus the necessity of obtaining 442 pre-treatment samples. Upregulation of CD169 has been described in SARS-CoV-2 443 syndrome, with speculation that it may be related to disease severity and mechanism. [33] 444 Upregulated CD38, a marker of monocyte/macrophage activation[34] has also been 445 observed in adults with severe SARS-CoV-2 syndrome. [25] 446 We also find that exhausted NK cell phenotypes are a major feature within our HLH/MAS) we included this patient in our FC group, as clinically in our institution we did 483 not categorize this patient as "MIS-C" and they did not present with the classic features 484 or lab findings (lymphopenia, relative thrombocytopenia) seen in MIS-C patients. Although we used all patients for flow cytometry analysis, the cytokine analysis 486 was limited by using on only a subset of patients. Thus, the cytokine findings are not 487 directly correlative of all of the flow cytometry data. Finally, the study is also limited by 488 the lack of more extensive markers to further evaluate NK cell activity, such as perforin, 489 NKD2D and CD16. This was due to our expectation that the primary pathology would 490 be found in the T cell compartment, and although T cell abnormalities were found in our 491 data, we were somewhat surprised by the evident NK cell findings. Future studies will 492 plan on dissecting changes in these cells more comprehensively. CD169(+) Macrophages 588 Capture and Dendritic Cells Instruct: The Interplay of the Gatekeeper and the General of the 589 Immune System Macrophages: a Trojan horse in COVID-19? CD38 Is 592 Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions. Front 593 Immunol Lectin-like Receptor G1 Inhibits NK Cell Function through Activation of Adenosine 5'-596 Monophosphate-Activated Protein Kinase Characterizing the Dysfunctional NK Cell: Assessing the 598 Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with 601 Specialized Functions in Immune Regulation Induction and 603 transcriptional regulation of the co-inhibitory gene module in T cells An IL-27/NFIL3 signalling axis 606 drives Tim-3 and IL-10 expression and T-cell dysfunction The Effect of Unconventional Cytokine Combinations on NK-608 Cell Responses to Viral Infection. Front Immunol CD161 610 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells. Front Immunol Multi-omic profiling reveals 613 widespread dysregulation of innate immunity and hematopoiesis in COVID-19 COVID-19 and cytokine storm syndrome: are there lessons from 616 macrophage activation syndrome? Interleukin-10 down-regulates 618 MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting 619 arrival and recycling Low monocyte human 621 leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. 622 Intensive Care Med Absence of MHC class II on 624 cDC1 dendritic cells triggers fatal autoimmunity to a cross-presented self-antigen CD4 T cell CM (central memory). (K) Histogram showing upregulated KLRG1 in MIS-C patients vs RCV, HC and FC patients Percent of KLRG1 hi NK cells seen in MIS-C vs RCV and FC patients. (M) MFI in like patients are shown for comparison 689 but statistical analysis not performed (line indicating where no statistical analysis 690 performed); (N) Percent of KLRG1 high, CD38-CD161+ NK cells in MIS-C vs RCV and 691 FC patients, MIS-C like patients again included. (O-T) Biaxial analysis of CD38 and 692 CD161 expression in KLRG1 high NK cells from MIS-C, FC, RCV, HC, MIS-C like and 693 in a febrile control with HLH. KLRG1 high NK cells were gated in all subgroups from the 694 same KLRG1 high region (red box Uniform Manifold Approximation and Projection (UMAP) analysis of T cell and 699 NK cell populations. (A) 10 selected FC, 5 MIS-C, 5 Recovery MIS-C patients demonstrate increased number of NK cells of two 701 phenotypes These cell populations are seen also in MIS-C like patients. MIS-C and FC patients 703 show decreased expression of a third phenotype Representative expression of cellular markers from one patient with MIS-C (B) and one 705 febrile control (C) demonstrating KLRG1, PD-1, TIGIT, LAG3, TIM3, BTLA, CD161 and 706 CD38. (D) Histogram of clusters indicated on previous diagrams as "red arrow" and 707 "blue arrow